Product Overview
Structure
Active substances:
thiamphenicol glycinate acetylcysteinate 810 mg,
disodium edetate
pharmachologic effect
FLUIMUZIL ANTIBIOTIC - mucolytic, antibacterial.
Indications
- acute and chronic bronchitis
- non-treatable pneumonia
- otitis
- sinusitis, pharyngitis, laryngitis
- preparation for bronchoscopy and bronchography.
Contraindications
- anemia, impaired blood formation (including in the past)
- severe impaired liver and / or kidney function
- hypersensitivity to the components of the drug Fluimucil antibiotic IT.
Side effects
Allergic reactions.
With intramuscular administration, a slight burning sensation at the injection site is possible, rarely - reticulocytopenia, anemia, leukopenia, neutropenia, thrombocytopenia.
When inhaled, reflex cough, local irritation of the respiratory tract, stomatitis, rhinitis, nausea. Bronchospasm is possible, in this case bronchodilators are prescribed.
Interaction
The simultaneous administration of antitussive drugs can increase sputum congestion due to suppression of the cough reflex.
It is not recommended to mix with other drugs in an aerosol.
How to take, course of administration and dosage
Adults - 300 mg 1-2 times a day. Children from 6 to 14 years old - 150 mg 1-2 times a day.
Overdose
Symptoms: a change in the bacterial flora, superinfection. Possible increased side effects of the drug (with the exception of allergic reactions).
Supportive therapy is recommended.
Special instructions
During treatment, the picture of peripheral blood should be monitored. With a decrease in the number of leukocytes (less than 4 thousand / μl) and granulocytes (more than 40%), the drug is canceled.
The Fluimucil-IT antibiotic solution must not come into contact with metal and rubber surfaces.
Fluimucil-antibiotic IT does not affect the ability to drive vehicles and other mechanisms.
Release form
Lyophilized powder for injection
